Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wallis

Showing results (251-260 of 273) with videos related to

Pageof 28
Sort By:
BMJ (Clinical Research Ed.)|May 29, 2004
Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women StudyEmily Banks, Gillian Reeves, Valerie Beral, et al.
Breast Cancer Research : BCR|January 19, 2006
Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effectEmily Banks, Gillian Reeves, Valerie Beral, et al.
AJR. American Journal of Roentgenology|May 23, 2014
Educational interventions to improve screening mammography interpretation: a randomized controlled trialBerta M Geller, Andy Bogart, Patricia A Carney, et al.
Clinical and Experimental Immunology|January 30, 2018
Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiencyC Evans, E Bateman, R Steven, et al.
Molecular Cancer Therapeutics|April 27, 2018
ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor GrowthGeorge A Ward, Edward J Lewis, Jong Sook Ahn, et al.
BMJ Open|January 8, 2022
Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study)David Jenkinson, Karoline Freeman, Karen Clements, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureusFrank Fan, Kang Yan, Nicola G Wallis, et al.
Biotechnology and Bioengineering|August 16, 2001
Production of tissue plasminogen activator (t-PA) in Aspergillus nigerM G Wiebe, A Karandikar, G D Robson, et al.
Breast (Edinburgh, Scotland)|January 9, 2022
Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 studyAnthony J Maxwell, Bridget Hilton, Karen Clements, et al.
BMJ Open|December 19, 2022
Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasiaKaren Clements, David Dodwell, Bridget Hilton, et al.
Pageof 28

Showing results (251-260 of 273) with videos related to

Sort By:
Pageof 28
BMJ (Clinical Research Ed.)|May 29, 2004
Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women StudyEmily Banks, Gillian Reeves, Valerie Beral, et al.
Breast Cancer Research : BCR|January 19, 2006
Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effectEmily Banks, Gillian Reeves, Valerie Beral, et al.
AJR. American Journal of Roentgenology|May 23, 2014
Educational interventions to improve screening mammography interpretation: a randomized controlled trialBerta M Geller, Andy Bogart, Patricia A Carney, et al.
Clinical and Experimental Immunology|January 30, 2018
Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiencyC Evans, E Bateman, R Steven, et al.
Molecular Cancer Therapeutics|April 27, 2018
ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor GrowthGeorge A Ward, Edward J Lewis, Jong Sook Ahn, et al.
BMJ Open|January 8, 2022
Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study)David Jenkinson, Karoline Freeman, Karen Clements, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureusFrank Fan, Kang Yan, Nicola G Wallis, et al.
Biotechnology and Bioengineering|August 16, 2001
Production of tissue plasminogen activator (t-PA) in Aspergillus nigerM G Wiebe, A Karandikar, G D Robson, et al.
Breast (Edinburgh, Scotland)|January 9, 2022
Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 studyAnthony J Maxwell, Bridget Hilton, Karen Clements, et al.
BMJ Open|December 19, 2022
Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasiaKaren Clements, David Dodwell, Bridget Hilton, et al.
Pageof 28